Calreticulin Mutation Status Predicts Improved Disease Outcome in Prefibrotic Primary Myelofibrosis but Not in WHO-Defined Essential ThrombocythemiaHeinz Gisslinger, Róbert Královics, Jelena D. Milosevic Feenstra et al.|Blood|2014Cited by 1
Correlation Of Longitudinal Blood Counts With Thromboembolic Complications In WHO 2008 Defined Prefibrotic Primary MyelofibrosisVeronika Buxhofer‐Ausch, Heinz Gisslinger, Martin Schalling et al.|Blood|2013Cited by 1
Survival in Essential Thrombocythemia and Prefibrotic Primary Myelofibrosis - Correlation of Clinical Phenotype with Histomorphological DiagnosisGeorg Jeryczynski, Heinz Gisslinger, Jürgen Thiele et al.|Blood|2016Cited by 0